Welcome to PharmAlliance International Labs Private Limited, where innovation meets excellence in pharmaceuticals. Our Cefdinir Range, proudly brought to you by AIT Pharmaceuticals Division, stands at the forefront of effective antibiotic therapy, symbolizing our unwavering commitment to global healthcare advancement.

Unveiling the Drug Class:

Cefdinir emerges as a distinguished member of the cephalosporin antibiotics, specifically classified as a third-generation cephalosporin. Renowned for its broad-spectrum activity against an extensive array of Gram-positive and Gram-negative bacteria, this class of antibiotics serves as a cornerstone in modern infectious disease management. With its potent bactericidal effect and versatility in combating bacterial infections, third-generation cephalosporins offer a robust solution for healthcare professionals worldwide, facilitating swift recovery and restoration of health.

Exploring Comprehensive Formulations:

Our Cefdinir Range presents a diverse array of formulations tailored to meet the diverse needs of clinical practice:

Cefdinir Dispersible Tablets (DS): Offering a strength of 125mg, our dispersible tablets provide a convenient option for oral suspension, packaged meticulously in bottles containing 60ml of oral suspension. Designed for ease of administration, our formulations ensure precision and reliability in dosage delivery.

Cefdinir Capsules: Featuring potent strengths of 100mg and 300mg, our hard gelatin capsules offer a versatile oral dosage form for efficient antibiotic therapy. Presented in blister packs of 10 capsules, our capsules ensure optimal patient compliance and ease of administration across diverse clinical settings.

Unlocking Therapeutic Applications:

Cefdinir stands as a versatile therapeutic agent, indicated for the treatment of various bacterial infections caused by susceptible organisms. From acute exacerbations of chronic bronchitis to community-acquired pneumonia and acute bacterial sinusitis, our Cefdinir Range addresses a spectrum of infectious diseases, ensuring comprehensive patient care and treatment outcomes.

Navigating Pharmacokinetics and Pharmacodynamics:

With its efficient absorption after oral administration and rapid achievement of peak plasma concentrations, Cefdinir ensures timely therapeutic action at the site of infection. By inhibiting bacterial cell wall synthesis and inducing cell death, Cefdinir exerts its potent bactericidal effect, offering a swift and decisive response to bacterial pathogens.

Guiding Usage and Dosage Recommendations:

Cefdinir tablets and dispersible tablets should be administered orally, with or without food, ensuring optimal drug absorption and efficacy. It is imperative to complete the full course of treatment as prescribed by healthcare providers, even if symptoms alleviate before the medication is completed. Dosage adjustments are tailored based on infection type, severity, and patient-specific factors, ensuring optimal therapeutic outcomes across diverse patient populations.

Embracing Excellence in Antibiotic Therapy:

Experience the efficacy and reliability of AIT Pharmaceuticals Division’s Cefdinir Range in the treatment of bacterial infections. For further information and inquiries, please do not hesitate to contact us. Together, let us redefine the standards of antibiotic therapy and pave the way for a healthier future.